SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Pasithea Therapeutics Corp.
@KTTA_InsiderForm 4 Filing: Coastlands Capital LP Buys $53,000 of $KTTA
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Pasithea Therapeutics Corp.
Ticker: $KTTA
Transaction Value
$53,000
Price/Share: $0.53
transaction date
2026-06-17
Shares: 100,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Coastlands Capital LP, holds the title of 10% Owner at Pasithea Therapeutics Corp..
On 2026-06-17, the insider transacted 100,000 shares.The shares were transacted at a weighted average price of $0.53 per share, resulting in a total market-relevant value of $53,000.
Executive Summary Summary
Coastlands Capital LP (10% Owner) bought $53K of $KTTA
Post-Transaction Position: 3,835,035 shares
SEC Accession No: 0001104659-26-076184 (CIK: 2068530)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.